(Q38830997)

6 September 2017

title

Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma (English)

1 reference

6 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Z Najafi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

G Javadi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

2 October 2015

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

530-535

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26427512%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2015.51

4 June 2020

exact match

0 references

cites work

miRBase: microRNA sequences, targets and gene nomenclature

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

An extensive class of small RNAs in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA Gene Networks in Oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

The etiology of hepatocellular carcinoma and consequences for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Cellular and molecular mechanisms of hepatocellular carcinoma: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

The PDCD4/miR-21 pathway in medullary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

microRNAs and their potential target genes in leukemia pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

(micro)Genomic medicine: microRNAs as therapeutics and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNAs as potential cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Sequence motifs associated with hepatotoxicity of locked nucleic acid--modified antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNAs: Potential biomarkers in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNAs and cancer therapy: the next wave or here to stay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNAs: novel regulators in the hallmarks of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNAs as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

Exosomal miRNAs: Biological Properties and Therapeutic Potential

21 January 2018

1 reference

12 December 2020

MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Modulation of miR-21 signaling by MPS1 in human glioblastoma

1 reference

12 December 2020

The role of microRNAs in biological processes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

7 January 2021

inferred from DOI database lookup

Abstract 1479: A miRNA signature distinguishing low-grade and high-grade gliomas shows miR-21 and 210 as promising biomarkers of aggressive phenotype and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2015.51

7 January 2021